BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 22973869)

  • 1. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.
    Ayyathurai R; Garcia-Roig M; Gorin MA; González J; Manoharan M; Kava BR; Soloway MS; Ciancio G
    BJU Int; 2012 Dec; 110(11 Pt B):E449-55. PubMed ID: 22540981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: single-center experience.
    Kondo T; Ikezawa E; Takagi T; Kobayashi H; Hashimoto Y; Iizuka J; Omae K; Yoshida K; Tanabe K
    Int J Urol; 2013 Nov; 20(11):1072-7. PubMed ID: 23421632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus.
    Lawindy SM; Kurian T; Kim T; Mangar D; Armstrong PA; Alsina AE; Sheffield C; Sexton WJ; Spiess PE
    BJU Int; 2012 Oct; 110(7):926-39. PubMed ID: 22540179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus.
    Abel EJ; Wood CG; Eickstaedt N; Fang JE; Kenney P; Bagrodia A; Youssef RF; Sagalowsky AI; Margulis V
    J Urol; 2013 Aug; 190(2):452-7. PubMed ID: 23434945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study.
    Steffens S; Janssen M; Roos FC; Becker F; Schumacher S; Seidel C; Wegener G; Thüroff JW; Hofmann R; Stöckle M; Siemer S; Schrader M; Hartmann A; Kuczyk MA; Junker K; Schrader AJ
    Eur J Cancer; 2012 Oct; 48(15):2347-52. PubMed ID: 22698386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.
    Terakawa T; Miyake H; Takenaka A; Hara I; Fujisawa M
    Int J Urol; 2007 Sep; 14(9):781-4. PubMed ID: 17760741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
    Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
    Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma.
    Zucchi A; Novara G; Costantini E; Antonelli A; Carini M; Carmignani G; Cosciani Cunico S; Fontana D; Longo N; Martignoni G; Minervini A; Mirone V; Porena M; Roscigno M; Schiavina R; Simeone C; Simonato A; Siracusano S; Terrone C; Ficarra V
    BJU Int; 2012 Apr; 109(8):1140-6. PubMed ID: 21871053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.
    Chen X; Li S; Xu Z; Wang K; Fu D; Liu Q; Wang X; Wu B
    World J Surg Oncol; 2015 Feb; 13():14. PubMed ID: 25650039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
    Shin S; Han Y; Park H; Chung YS; Ahn H; Kim CS; Cho YP; Kwon TW
    J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of venous tumor thrombus in renal cell carcinoma].
    García-Fadrique G; Budía-Alba A; Ruiz-Cerdá JL; Morales-Solchaga G; Pontones JL; Jiménez-Cruz JF
    Actas Urol Esp; 2012 Jan; 36(1):29-34. PubMed ID: 21802784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy.
    Kwon T; Lee JL; You D; Jeong IG; Song C; Ahn H; Kim CS; Hong JH
    J Surg Oncol; 2014 Aug; 110(2):145-50. PubMed ID: 24706355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.